FAM98A was shown to promote the progression of endometrial carcinoma (Li et al. 2019), non-small cell lung cancer (Zheng et al. 2018), and breast cancer (Liu et al. 2021), and we also revealed the role of FAM98A in the risk of HNSCC in the present study. Here, TSLIG3A is linked to breast cancer.